Association of Anti-VEGF Therapy with Reported Ocular Adverse Events: A Global Pharmacovigilance Analysis

Macular DiseasesRetinal Diseases

Ocular Adverse Events Associated with Pegcetacoplan and Avacincaptad Pegol for Geographic Atrophy: A Population-Based Pharmacovigilance Study: Ocular Adverse Events of Pegcetacoplan & Avacincaptad Pegol

Am J Ophthalmol

Kailani Z, Mihalache A, Popovic MM, Kertes PJ, Muni RH

doi: 10.1016/j.ajo.2025.04.022

Further Publications

Comparison of Renal Adverse Events Between Intravitreal Anti-Vascular Endothelial Growth Factor Agents: A Meta-Analysis

Am J Ophthalmol

Huang RS, Balas M, Jhaveri A, Popovic MM, Kertes PJ, Muni RH

doi: 10.1016/j.ajo.2024.12.023

Macular Diseases

Real-World 10-Year Outcomes of Anti-VEGF Therapy for Neovascular Age-Related Macular Degeneration: A Meta-Analysis

Clin Exp Ophthalmol

Spooner K, Broadhead G, Fraser-Bell S, Hong T, Wong JG, Chang AA

doi: 10.1111/ceo.14559

Retinal Diseases

Treatment Patterns and Long-Term Outcomes with Anti-VEGF Therapy for Retinal Vein Occlusion: An Analysis of the Vestrum Database

Ophthalmol Retina

Ip M, Modi Y, Fekrat S, Gibson K, Boucher N, Arrisi P, Ishii F, Liu Y, Paris LP, Fenech M, Chi GC

doi: 10.1016/j.oret.2025.05.025

Macular Diseases

Cost-minimisation analysis of anti-VEGF therapies in neovascular age-related macular degeneration and diabetic macular oedema in Switzerland

J Med Econ

Ambresin A, Quist SW, Boer M, Maamari S, Barthelmes D

doi: 10.1080/13696998.2025.2536420

Macular Diseases

Comparative efficacy of intravitreal anti-VEGF therapy for neovascular age-related macular degeneration: A systematic review with network meta-analysis

Acta Ophthalmol

Butler ETS, Arnold-Vangsted A, Schou MG, Anguita R, Bjerager J, Borrelli E, Cehofski LJ, Ferro Desideri L, van Dijk EHC, Faber C, Grauslund J, Hajari JN, Huemer J, Klefter ON, Krogh Nielsen M, Sabaner MC, Schneider M, Subhi Y

doi: 10.1111/aos.17506

Retinal Diseases

Clinical characteristics associated with complications and poor visual outcomes in ocular toxoplasmosis: Analysis of 853 patients: complications and visual outcomes in ocular toxoplasmosis

Am J Ophthalmol

de-la-Torre A, Mejía-Salgado G, Cifuentes-González C, Cuevas M, García S, Rangel CM, Durán C, Pachón-Suárez DI, Bustamante-Arias A, Rojas-Carabali W

doi: 10.1016/j.ajo.2025.02.027

Retinal Diseases

Placental Transcriptomic Analysis in Retinopathy of Prematurity Reactivation after Anti-VEGF Treatment

Am J Ophthalmol

Kang J, Kim S, Bae JG, Jang JH

doi: 10.1016/j.ajo.2025.07.023

Further Publications

Ophthalmic Immune-Related Adverse Events and Association with Survival: Results from a Real-World Database

Am J Ophthalmol

Quiruz L, Yavari N, Kikani B, Gupta AS, Wai KM, Kossler AL, Ludwig C, Koo EB, Rahimy E, Mruthyunjaya P

doi: 10.1016/j.ajo.2024.08.044

Related content

Ocular Adverse Events Associated with Pegcetacoplan and Avacincaptad Pegol for Geographic Atrophy: A Population-Based Pharmacovigilance Study: Ocular Adverse Events of Pegcetacoplan & Avacincaptad Pegol

Comparison of Renal Adverse Events Between Intravitreal Anti-Vascular Endothelial Growth Factor Agents: A Meta-Analysis

Real-World 10-Year Outcomes of Anti-VEGF Therapy for Neovascular Age-Related Macular Degeneration: A Meta-Analysis

Treatment Patterns and Long-Term Outcomes with Anti-VEGF Therapy for Retinal Vein Occlusion: An Analysis of the Vestrum Database

Cost-minimisation analysis of anti-VEGF therapies in neovascular age-related macular degeneration and diabetic macular oedema in Switzerland

Comparative efficacy of intravitreal anti-VEGF therapy for neovascular age-related macular degeneration: A systematic review with network meta-analysis

Clinical characteristics associated with complications and poor visual outcomes in ocular toxoplasmosis: Analysis of 853 patients: complications and visual outcomes in ocular toxoplasmosis

Placental Transcriptomic Analysis in Retinopathy of Prematurity Reactivation after Anti-VEGF Treatment

Ophthalmic Immune-Related Adverse Events and Association with Survival: Results from a Real-World Database